La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
COO Aperçu des actions
The Cooper Companies, Inc. et ses filiales développent, fabriquent et commercialisent des lentilles de contact.
| Score flocon de neige | |
|---|---|
| Évaluation | 2/6 |
| Croissance future | 3/6 |
| Performances passées | 4/6 |
| Santé financière | 5/6 |
| Dividendes | 0/6 |
Récompenses
Analyse des risques
Aucun risque n'a été détecté pour COO à partir de nos contrôles de risques.
The Cooper Companies, Inc. Concurrents
Historique des prix et performances
| Historique des cours de bourse | |
|---|---|
| Prix actuel de l'action | US$95.89 |
| Plus haut sur 52 semaines | US$104.07 |
| Plus bas sur 52 semaines | US$75.94 |
| Bêta | 0.98 |
| 1Variation sur 1 mois | 5.66% |
| Variation sur 3 mois | -0.73% |
| Variation sur 1 an | 3.61% |
| 3Variation sur 3 ans | -14.34% |
| Variation sur 5 ans | 17.52% |
| Évolution depuis l'introduction en bourse | 1,143.20% |
Nouvelles et mises à jour récentes
Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17
Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Recent updates
Investors Interested In The Cooper Companies, Inc.'s (NASDAQ:COO) Earnings
Aug 17Is There Now An Opportunity In The Cooper Companies, Inc. (NASDAQ:COO)?
Jul 30Is There An Opportunity With The Cooper Companies, Inc.'s (NASDAQ:COO) 36% Undervaluation?
Jun 20Cooper Companies: Business Growth Noted, Valuations An Ask
Jun 14Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
May 21With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
May 02Should You Think About Buying The Cooper Companies, Inc. (NASDAQ:COO) Now?
Apr 17The Cooper Companies: Rating Upgrade As Near-Term Momentum Should Continue
Mar 22Calculating The Intrinsic Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Mar 18The Cooper Companies: I Still Don't See Much Upside
Mar 01These 4 Measures Indicate That Cooper Companies (NASDAQ:COO) Is Using Debt Reasonably Well
Jan 23Cooper Companies: Women Health Business Makes Room For Growth; Path For Margin Expansion
Jan 15When Should You Buy The Cooper Companies, Inc. (NASDAQ:COO)?
Jan 08With The Cooper Companies, Inc. (NASDAQ:COO) It Looks Like You'll Get What You Pay For
Dec 24A Look At The Fair Value Of The Cooper Companies, Inc. (NASDAQ:COO)
Nov 30Investors Could Be Concerned With Cooper Companies' (NASDAQ:COO) Returns On Capital
Oct 30What Does The Cooper Companies, Inc.'s (NASDAQ:COO) Share Price Indicate?
Sep 28Cooper Offers A Great Business But A Somewhat Tricky Valuation
Sep 25Here's Why Cooper Companies (NYSE:COO) Can Manage Its Debt Responsibly
Sep 10Calculating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Aug 23Cooper Companies (NYSE:COO) Is Reinvesting At Lower Rates Of Return
Jul 24The Cooper Companies: Valuation Is Too High (Rating Downgrade)
Jul 12When Should You Buy The Cooper Companies, Inc. (NYSE:COO)?
Jun 24Is Cooper Companies (NYSE:COO) Using Too Much Debt?
Jun 08Estimating The Intrinsic Value Of The Cooper Companies, Inc. (NYSE:COO)
May 24Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Apr 23At US$355, Is The Cooper Companies, Inc. (NYSE:COO) Worth Looking At Closely?
Mar 25These 4 Measures Indicate That Cooper Companies (NYSE:COO) Is Using Debt Reasonably Well
Feb 04Cooper Companies: Growth Comes At A High Cost To Equity Holders, Rate Hold
Jan 30Estimating The Fair Value Of The Cooper Companies, Inc. (NYSE:COO)
Jan 19Investors Could Be Concerned With Cooper Companies' (NYSE:COO) Returns On Capital
Jan 04Cooper Cos. initiated at buy at Mizuho on contact lenses, cataract implants positioning
Dec 22Is It Too Late To Consider Buying The Cooper Companies, Inc. (NYSE:COO)?
Dec 20The Cooper Companies declares $0.03 dividend
Dec 14The Cooper Companies Non-GAAP EPS of $2.75 misses by $0.36, revenue of $848.1M beats by $9.22M
Dec 08Cooper Companies: Questions On Viability Of Future Earnings Upside
Nov 04Are Investors Undervaluing The Cooper Companies, Inc. (NYSE:COO) By 38%?
Oct 18BioSkryb, Cooper ink license deal for genomic technology for women's reproductive health
Oct 18Be Wary Of Cooper Companies (NYSE:COO) And Its Returns On Capital
Oct 03The Cooper Companies Non-GAAP EPS of $3.19 misses by $0.04, revenue of $843.4M beats by $13.18M
Aug 31Is Now The Time To Look At Buying The Cooper Companies, Inc. (NYSE:COO)?
Aug 30Cooper Companies: The Perfect Harbor For A Perfect Storm
Aug 18Cooper Companies (NYSE:COO) Seems To Use Debt Quite Sensibly
Aug 03Rendement pour les actionnaires
| COO | US Medical Equipment | US Marché | |
|---|---|---|---|
| 7D | 4.2% | 2.4% | 3.1% |
| 1Y | 3.6% | 9.8% | 25.4% |
Rendement vs Industrie: COO a sous-performé le secteur US Medical Equipment qui a rapporté 11.2 % au cours de l'année écoulée.
Rendement vs marché: COO a sous-performé le marché US qui a rapporté 25.6 % au cours de l'année écoulée.
Volatilité des prix
| COO volatility | |
|---|---|
| COO Average Weekly Movement | 3.0% |
| Medical Equipment Industry Average Movement | 8.2% |
| Market Average Movement | 6.3% |
| 10% most volatile stocks in US Market | 15.0% |
| 10% least volatile stocks in US Market | 3.2% |
Cours de l'action stable: COO n'a pas connu de volatilité de prix significative au cours des 3 derniers mois.
Volatilité au fil du temps: La volatilité hebdomadaire de COO ( 3% ) est restée stable au cours de l'année écoulée.
À propos de l'entreprise
| Fondée | Salariés | PDG | Site web |
|---|---|---|---|
| 1958 | 15,000 | Al White | www.coopercos.com |
The Cooper Companies, Inc. et ses filiales développent, fabriquent et commercialisent des lentilles de contact. La société opère dans deux segments, CooperVision et CooperSurgical. Le segment CooperVision fournit des lentilles sphériques, y compris des lentilles qui corrigent la myopie et l'hypermétropie, ainsi que des lentilles toriques et multifocales comprenant des lentilles qui corrigent les problèmes de vision, tels que l'astigmatisme, la presbytie et la myopie, en Amérique, en Europe, au Moyen-Orient, en Afrique et en Asie-Pacifique.
The Cooper Companies, Inc. Résumé des fondamentaux
| COO statistiques fondamentales | |
|---|---|
| Capitalisation boursière | US$18.96b |
| Bénéfices(TTM) | US$339.90m |
| Recettes(TTM) | US$3.73b |
56.2x
Ratio P/E5.1x
Ratio P/SLe site COO est-il surévalué ?
Voir Juste valeur et analyse de l'évaluationBénéfices et recettes
| COO compte de résultat (TTM) | |
|---|---|
| Recettes | US$3.73b |
| Coût des recettes | US$1.26b |
| Marge brute | US$2.47b |
| Autres dépenses | US$2.13b |
| Les revenus | US$339.90m |
Derniers bénéfices déclarés
Apr 30, 2024
Prochaine date de publication des résultats
Aug 28, 2024
| Résultat par action (EPS) | 1.71 |
| Marge brute | 66.23% |
| Marge bénéficiaire nette | 9.11% |
| Ratio dettes/capitaux propres | 34.7% |
Quelles ont été les performances à long terme de COO?
Voir les performances historiques et les comparaisons